ReNeuron Group PLC RQE1-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 06/11/21 CEST
1.33quote price arrow up+0.09 (+7.26%)
52 week range
0.79 - 1.69

...

Loading . . .
  • Open1.23
  • Day High1.33
  • Day Low1.23
  • Prev Close1.24
  • 52 Week High1.69
  • 52 Week High Date05/07/21
  • 52 Week Low0.79
  • 52 Week Low Date12/16/20

Key Stats

  • Market Cap53.87M
  • Shares Out32.74M
  • 10 Day Average Volume272.5
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change49.44

KEY STATS

  • Open1.23
  • Day High1.33
  • Day Low1.23
  • Prev Close1.24
  • 52 Week High1.69
  • 52 Week High Date05/07/21
  • 52 Week Low0.79
  • 52 Week Low Date12/16/20
  • Market Cap53.87M
  • Shares Out32.74M
  • 10 Day Average Volume272.5
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change49.44

RATIOS/PROFITABILITY

  • EPS (TTM)-0.49
  • P/E (TTM)-2.71
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ReNeuron Group PLC

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
ReNeuron Group plc is a United Kingdom-based cell-based therapeutics company. The Company develops allogeneic stem cell technology platforms, stem cell derived exosomes and induced pluripotent stem cells. The Company's products are allogeneic. Its CTX stem cell therapy is used for the treatment of patients left disabled by the effects of a stroke. Its human retinal progenitor cells (hRPC) stem cell candidate is used for the treatment of retinitis pigmentosa (RP). The...
Timothy Corn
Non-Executive Chairman
Olav Hellebo
Chief Executive Officer
Shaun Stapleton
Vice President
Address
Pencoed Business Park
Bridgend
CF35 5HY
United Kingdom